quantitative whole body PET studies
An Investigation of the Required MR Bone Attenuation Correction for Quantitative Whole Body PET/MR Imaging Using Clinical NaF PET/CT Studies
23
Feasibility of PET/CT system performance harmonisation for quantitative multicentre 89Zr studies
8
Effects of ferumoxytol on quantitative PET measurements in simultaneous PET/MR whole-body imaging: a pilot study in a baboon model
12
Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT
8
Whole-body MRI versus <sup>18</sup>F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis
12
High bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRI
9
Impact of Integrated Whole Body 68Ga PET/MR Imaging in Comparison with 68Ga PET/CT in Lesions Detection and Diagnosis of Suspected Neuroendocrine Tumours
10
Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer
12
Monitoring scanner calibration using the image-derived arterial blood SUV in whole-body FDG-PET
9
Whole-body 18FDG PET plus pelvic MRI in the pre-treatment assessment of cervical cancers: an alternative to the FIGO clinical staging
6
18 F Fluoride positron emission tomography/computed tomography for noninvasive in vivo quantification of pathophysiological bone metabolism in experimental murine arthritis
9
Clinical studies using a high sensitivity shadow shield mobile whole body monitor
188
Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
14
Quantitative Analysis of Simultaneous EEG Features during PET Studies for Childhood Partial Epilepsy
6
Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model
11
Dual effects of fibroblast growth factor 21 on hepatic energy metabolism
28
Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers
6
18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition
7
Clinical value of whole body PET/CT in patients with active rheumatic diseases
12
MRI-Based Attenuation Correction in Emission Computed Tomography
226